TABLE 4.
Strain description | IC (m2/J) for treatment
|
|||
---|---|---|---|---|
UV-C, 254 nm | UV-(A+B), 280-400 nm | UV-(A+B), 290-400 nm | UV-A, 320-400 nm | |
Wild type | (6.9 ± 0.7) × 10−3 | (1.9 ± 0.3) × 10−4 | (1.6 ± 0.2) × 10−4 | (4.5 ± 0.4) × 10−6 |
dacB | (7.0 ± 0.9) × 10−3 | (2.5 ± 0.4) × 10−4 | (2.4 ± 0.3) × 10−4* | (6.4 ± 0.5) × 10−6* |
sspA | (9.8 ± 0.8) × 10−3* | (3.1 ± 0.3) × 10−4* | (3.5 ± 0.2) × 10−4* | (7.6 ± 0.8) × 10−6* |
sspB | (8.9 ± 0.6) × 10−3* | (2.8 ± 0.5) × 10−4* | (3.0 ± 0.3) × 10−4* | (6.9 ± 0.7) × 10−6* |
sspE | (7.2 ± 0.7) × 10−3 | (2.0 ± 0.4) × 10−4 | (1.6 ± 0.1) × 10−4 | (4.8 ± 0.5) × 10−6 |
sspA sspB | (1.1 ± 0.2) × 10−2* | (4.1 ± 0.7) × 10−4* | (4.3 ± 0.8) × 10−4* | (9.6 ± 1.3) × 10−6* |
The IC, i.e., the slope of the semilogarithmic survival curves (see Materials and Methods), was determined for each strain and each treatment.
Data are averages and standard deviations (n = 4). Asterisks indicate IC values that were significantly different from the respective wild-type IC (P ≤ 0.05).